Open Access. Powered by Scholars. Published by Universities.®
Zucker School of Medicine at Hofstra/Northwell
Antipsychotic-drugs;; regression-models;; psychosis;; risperidone;; olanzapine;; efficacy;; trial;; haloperidol;; medications;; disparities;; Psychiatry
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Prescription Practices In The Treatment Of First-Episode Schizophrenia Spectrum Disorders: Data From The National Raise-Etp Study, D. G. Robinson, N. R. Schooler, M. John, C. U. Correll, P. Marcy, J. Severe, A. Goldstein, S. Azrin, R. Heinssen, J. M. Kane, +7 Additional Authors
Prescription Practices In The Treatment Of First-Episode Schizophrenia Spectrum Disorders: Data From The National Raise-Etp Study, D. G. Robinson, N. R. Schooler, M. John, C. U. Correll, P. Marcy, J. Severe, A. Goldstein, S. Azrin, R. Heinssen, J. M. Kane, +7 Additional Authors
Journal Articles
Objective: Treatment guidelines suggest distinctive medication strategies for first-episode and multiepisode patients with schizophrenia. To assess the extent to which community clinicians adjust their usual treatment regimens for first-episode patients, the authors examined prescription patterns and factors associated with prescription choice in a national cohort of early-phase patients. Method: Prescription data at study entry were obtained from 404 participants in the Recovery After an Initial Schizophrenia Episode Project's Early Treatment Program (RAISE-ETP), a nationwide multisite effectiveness study for patients with first-episode schizophrenia spectrum disorders. Treatment with antipsychotics did not exceed 6 months at study entry. Results: The authors identified 159 …